Literature DB >> 18167353

Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei.

Munender Vodnala1, Artur Fijolek, Reza Rofougaran, Marc Mosimann, Pascal Mäser, Anders Hofer.   

Abstract

African sleeping sickness is caused by Trypanosoma brucei. This extracellular parasite lacks de novo purine biosynthesis, and it is therefore dependent on exogenous purines such as adenosine that is taken up from the blood and other body fluids by high affinity transporters. The general belief is that adenosine needs to be cleaved to adenine inside the parasites in order to be used for purine nucleotide synthesis. We have found that T. brucei also can salvage this nucleoside by adenosine kinase (AK), which has a higher affinity to adenosine than the cleavage-dependent pathway. The recombinant T. brucei AK (TbAK) preferably used ATP or GTP to phosphorylate both natural and synthetic nucleosides in the following order of catalytic efficiencies: adenosine > cordycepin > deoxyadenosine > adenine arabinoside (Ara-A) > inosine > fludarabine (F-Ara-A). TbAK differed from the AK of the related intracellular parasite Leishmania donovani by having a high affinity to adenosine (K m = 0.04-0.08 microm depending on [phosphate]) and by being negatively regulated by adenosine (K i = 8-14 microm). These properties make the enzyme functionally related to the mammalian AKs, although a phylogenetic analysis grouped it together with the L. donovani enzyme. The combination of a high affinity AK and efficient adenosine transporters yields a strong salvage system in T. brucei, a potential Achilles' heel making the parasites more sensitive than mammalian cells to adenosine analogs such as Ara-A. Studies of wild-type and AK knockdown trypanosomes showed that Ara-A inhibited parasite proliferation and survival in an AK-dependent manner by affecting nucleotide levels and by inhibiting nucleic acid biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18167353     DOI: 10.1074/jbc.M705603200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Trypanosoma brucei thymidine kinase is tandem protein consisting of two homologous parts, which together enable efficient substrate binding.

Authors:  Farahnaz Ranjbarian; Munender Vodnala; Sharvani Munender Vodnala; Reza Rofougaran; Lars Thelander; Anders Hofer
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

2.  Structures of adenosine kinase from Trypanosoma brucei brucei.

Authors:  Jennifer Timm; Dolores González-Pacanowska; Keith S Wilson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

3.  9-(2'-Deoxy-2'-Fluoro-β-d-Arabinofuranosyl) Adenine Is a Potent Antitrypanosomal Adenosine Analogue That Circumvents Transport-Related Drug Resistance.

Authors:  Farahnaz Ranjbarian; Munender Vodnala; Khalid J H Alzahrani; Godwin U Ebiloma; Harry P de Koning; Anders Hofer
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 4.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

5.  A high-affinity adenosine kinase from Anopheles gambiae.

Authors:  María B Cassera; Meng-Chiao Ho; Emilio F Merino; Emmanuel S Burgos; Agnes Rinaldo-Matthis; Steven C Almo; Vern L Schramm
Journal:  Biochemistry       Date:  2011-02-15       Impact factor: 3.162

Review 6.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

7.  Trypanosoma brucei Methylthioadenosine Phosphorylase Protects the Parasite from the Antitrypanosomal Effect of Deoxyadenosine: IMPLICATIONS FOR THE PHARMACOLOGY OF ADENOSINE ANTIMETABOLITES.

Authors:  Munender Vodnala; Farahnaz Ranjbarian; Anna Pavlova; Harry P de Koning; Anders Hofer
Journal:  J Biol Chem       Date:  2016-04-01       Impact factor: 5.157

8.  Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin.

Authors:  Suman K Vodnala; Marcela Ferella; Hilda Lundén-Miguel; Evans Betha; Nick van Reet; Daniel Ndem Amin; Bo Oberg; Björn Andersson; Krister Kristensson; Hans Wigzell; Martin E Rottenberg
Journal:  PLoS Negl Trop Dis       Date:  2009-08-04

9.  Adenosine Kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics.

Authors:  Sabine Kuettel; Marc Mosimann; Pascal Mäser; Marcel Kaiser; Reto Brun; Leonardo Scapozza; Remo Perozzo
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

10.  Acyclic nucleoside phosphonates with adenine nucleobase inhibit Trypanosoma brucei adenine phosphoribosyltransferase in vitro.

Authors:  Eva Doleželová; Tomáš Klejch; Petr Špaček; Martina Slapničková; Luke Guddat; Dana Hocková; Alena Zíková
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.